PreprintAll rights reservedmedRxiv
Cerebrospinal fluid dopa-decarboxylase is a biomarker of dopaminergic dysfunction
- 1Department of Medicine and Surgery, Section of Physiology and Biochemistry, University of Perugia, 06132 Perugia, Italy
Related
- Cerebrospinal fluid MMP-2 and TIMP-2 reflect blood–cerebrospinal fluid barrier dysfunction in Guillain–Barré syndrome and CIDP
- Neurofilaments in cerebrospinal fluid and/or serum as a possible biomarker of pediatric spinal muscular atrophy.
- Convergence of Cerebrospinal Fluid Neuronal Biomarker Burden and MRI Lesion Pattern and Its Association With Short-Term Outcome in Neuroinfectious Diseases.
- Development and Temporal Validation of a Three-Metabolite Cerebrospinal Fluid Model for the Diagnosis of Leptomeningeal Metastasis from Solid Tumors
- Cerebrospinal fluid metabolite alterations associated with human brain aging: an untargeted metabolomics study
BibTeX
@misc{sperandei2026cerebrospinal,
title = {{Cerebrospinal fluid dopa-decarboxylase is a biomarker of dopaminergic dysfunction}},
author = {S. Sperandei and F. Paolini Paoletti and M. De Pauw and L. Gaetani and C. Tranfaglia and J. Goossens and E. Stoops and E. Vanmechelen and L. Parnetti and G. Bellomo and D. Chiasserini},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.13.26364985},
url = {https://www.medrxiv.org/content/10.64898/2026.10.13.26364985v1},
}
RIS
TY - UNPB
TI - Cerebrospinal fluid dopa-decarboxylase is a biomarker of dopaminergic dysfunction
AU - S. Sperandei
AU - F. Paolini Paoletti
AU - M. De Pauw
AU - L. Gaetani
AU - C. Tranfaglia
AU - J. Goossens
AU - E. Stoops
AU - E. Vanmechelen
AU - L. Parnetti
AU - G. Bellomo
AU - D. Chiasserini
PY - 2026
DA - 2026/10/13
PB - medRxiv
DO - 10.64898/2026.10.13.26364985
UR - https://www.medrxiv.org/content/10.64898/2026.10.13.26364985v1
ER -